Literature DB >> 7865491

Effects of long-term treatment of captopril and enalapril on rat intestinal angiotensin converting enzyme specific activities.

S Song1, K W Yim, N Y Kim, B C Yoon, D H Lee, H C Jung, C Y Kim.   

Abstract

OBJECTIVES: Angiotensin converting enzyme (ACE) has been shown to be an important peptidasse that play a role in digestion and assimilation of protein rich in proline such as casein, gliadin and collagen. Despite that ACE inhibitors have been popular for various types of hypertension and congestive heart failure, the effects of their long-term treatment on intestinal ACE activities are not known. Therefore, we measured intestinal specific activities in rats after four weeks' treatment of ACE inhibitors.
METHODS: Thirty Wistar rats weighing about 200g in average were divided into three groups, and supplied with tap water, captopril solution and enalapril solution respectively for four weeks. After sacrificing, intestinal ACE specific activities were measured in homogenate and brush border membrane fraction respectively, which was prepared from three equally divided segments of removed small intestine.
RESULTS: ACE specific activities of proximal, middle and distal segments of control group were 178.6 +/- 64.2, 180.3 +/- 60.2 and 48.6 +/- 13.1 in brush border membrane (mean +/- SD, nmol/min/mg protein) respectively. Those of captopril group were 314.2 +/- 72.5, 281.0 +/- 69.8 and 67.7 +/- 21.8 respectively, showing tendency of increase in proximal and middle segments (p < 0.01 and 0.05 respectively). By contrast, those of enalapril group were 48.5 +/- 27.6, 70.7 +/- 15.6 and 11.6 +/- 4.4 respectively, which were significantly lower (p < 0.01) than those of control group.
CONCLUSION: Rat intestinal ACE specific activities were not inhibited by captopril treatment, but inhibited by enalapril treatment. This finding may explain why there has not been any case report of malabsorption in patients taking captopril. But the malabsorption of prolyl peptide could be possible in cases with long-term administration of enalapril.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865491      PMCID: PMC4532061          DOI: 10.3904/kjim.1994.9.2.67

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  19 in total

1.  Intestinal effects of captopril.

Authors:  I R Edwards; D M Coulter; D Macintosh
Journal:  BMJ       Date:  1992-02-08

2.  Role of rat intestinal brush-border membrane angiotensin-converting enzyme in dietary protein digestion.

Authors:  M Yoshioka; R H Erickson; J F Woodley; R Gulli; D Guan; Y S Kim
Journal:  Am J Physiol       Date:  1987-12

3.  Consequences of fluid loss in patients treated with ACE inhibitors.

Authors:  J McMurray; D M Matthews
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

4.  Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca.

Authors:  H S Cheung; D W Cushman
Journal:  Biochim Biophys Acta       Date:  1973-02-15

5.  Concentrations of angiotensin-converting enzyme in tissues of the rat.

Authors:  D W Cushman; H S Cheung
Journal:  Biochim Biophys Acta       Date:  1971-10

6.  Converting enzyme, kininase and angiotensinase of renal and intestinal brush border.

Authors:  P E Ward; M S Sheridan
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

7.  Angiotensin I converting enzyme (kininase II) of the brush border of human and swine intestine.

Authors:  P E Ward; M A Sheridan; K J Hammon; E G Erdös
Journal:  Biochem Pharmacol       Date:  1980-06-01       Impact factor: 5.858

8.  Tissue distribution of angiotensin converting enzyme in the rat: effect of captopril treatment.

Authors:  T Forslund; I Kouvonen; F Fyhrquist
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1984-02

9.  Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme).

Authors:  H Y Yang; E G Erdös; Y Levin
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

10.  Human intestinal brush border angiotensin-converting enzyme activity and its inhibition by antihypertensive Ramipril.

Authors:  B R Stevens; A Fernandez; C Kneer; J J Cerda; M I Phillips; E R Woodward
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.